Literature DB >> 3771508

Protein kinase C phosphorylates a recently identified membrane skeleton-associated calmodulin-binding protein in human erythrocytes.

E Ling, K Gardner, V Bennett.   

Abstract

A membrane skeleton-associated protein with calmodulin-binding activity recently has been purified and characterized from human erythrocytes (Gardner, K. and Bennett, V. (1986) J. Biol. Chem. 261, 1339-1348). This new protein (CaM-BP103/97) has now been identified as a major substrate for protein kinase C in erythrocytes since phosphorylation of both of its subunits (Mr = 103,000 and 97,000) is elevated 3-15-fold in the presence of the phorbol ester, 12-O-tetradecanoylphorbol beta-acetate (TPA), under the following conditions: ghost membranes incubated with protein kinase C purified from rat brain, ghost membranes from erythrocytes pretreated with TPA, and intact erythrocytes metabolically labeled with 32PO4 and stimulated by TPA. The sites of phosphorylation of this protein by exogenous and endogenous protein kinase C are identical since two-dimensional 32P-peptide maps of both subunits labeled by either endogenous or exogenous enzyme are indistinguishable. Each subunit of CaM-BP103/97 accepts up to 3 mol of phosphate/polypeptide chain. In the presence of low calcium concentrations and in the absence of cytosol, the phosphorylation of CaM-BP103/97 is, on a molar basis, equal to or greater than that of proteins 4.1 and 4.9. As a target for both calmodulin and protein kinase C, CaM-BP103/97 is likely to play a key role in the effect of calcium on erythrocyte membrane shape and stability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

2.  Adducin promotes micrometer-scale organization of beta2-spectrin in lateral membranes of bronchial epithelial cells.

Authors:  Khadar M Abdi; Vann Bennett
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

Review 3.  Role of the phosphorylation of red blood cell membrane proteins.

Authors:  P Boivin
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

4.  Identification of phosphatidylserine-binding proteins in human white blood cells.

Authors:  M Wolf; M Baggiolini
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

5.  Chromosomal localization of the beta-adducin gene to mouse chromosome 6 and human chromosome 2.

Authors:  R A White; S V Angeloni; L M Pasztor
Journal:  Mamm Genome       Date:  1995-10       Impact factor: 2.957

Review 6.  Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: the role of protein kinase C, Rac GTPases, and reactive oxygen species.

Authors:  Alex George; Suvarnamala Pushkaran; Lina Li; Xiuli An; Yi Zheng; Narla Mohandas; Clinton H Joiner; Theodosia A Kalfa
Journal:  Blood Cells Mol Dis       Date:  2010-03-15       Impact factor: 3.039

7.  A 20 kDa erythrocyte membrane phosphoprotein.

Authors:  S Lee; E B Cunningham; N I Swislocki
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

8.  Leukocyte chemoattraction by 1,2-diacylglycerol.

Authors:  T M Wright; R D Hoffman; J Nishijima; L Jakoi; R Snyderman; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Calmodulin-binding domain of recombinant erythrocyte beta-adducin.

Authors:  D A Scaramuzzino; J S Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Targeted deletion of the gamma-adducin gene (Add3) in mice reveals differences in alpha-adducin interactions in erythroid and nonerythroid cells.

Authors:  Kenneth E Sahr; Amy J Lambert; Steven L Ciciotte; Narla Mohandas; Luanne L Peters
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.